Mulmit

TScan Therapeutics, Inc.TScan Therapeutics, Inc.

TCRX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3110,325,000-135,813,000-129,766,000-1
2024-12-312,816,000-134,821,000-127,499,000-1.14
2023-12-3121,049,000-93,458,000-89,218,000-1.36
2022-12-3113,535,000-66,636,000-66,221,000-2.75
2021-12-3110,141,000-48,641,000-48,625,000-4.17

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-05-20BAKER BROS. ADVISORS LP67,000
2026-05-20BAKER BROS. ADVISORS LP67,000
2026-05-20Woods Keith67,000
2026-05-20Nicholson Garry A67,000
2026-05-20Gruia Gabriela67,000
2026-05-20Dorton Katina67,000
2026-05-20Klencke Barbara67,000
2026-01-20Amello JasonChief Financial Officer350,000
2026-01-20MacBeath GavinChief Executive Officer1,165,000
2026-01-20Dworak LeidenSee Remarks100,000
2026-01-20Louis ChrystalChief Medical Officer420,000
2026-01-20ZDRAVESKI ZORANSee Remarks350,000

8-K events

FiledItems
2026-09-11Officer or director change
2026-09-02Costs associated with exit or disposal activities · Delisting or listing-standard notice · Officer or director change · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-08-18Termination of a material agreement
2026-08-12Results of operations · Financial statements and exhibits
2026-06-22Regulation FD disclosure · Other events · Financial statements and exhibits
2026-05-22Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-05-06Results of operations · Financial statements and exhibits
2026-04-02Officer or director change
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.